Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Genovis and Glykos partner to enable new ADC platform

Genovis AB and Glykos Finland Oy have today entered into a licensing and supply agreement for state-of-the-art linker-payload technologies to be combined with the site-specific antibody conjugation platform offered by Genovis.By using GlyCLICK®, a site-specific antibody conjugationtechnology from Genovis and the latest novel linker and cytotoxic drug derivatives from Glykos,Genovis will offer biopharma customers a platform to screen and develop Antibody Drug Conjugates (ADCs) with improved performance. The partnership between Genovis and Glykos will enable scientists around the world to

Relics from Shakespeare’s home shared in new virtual exhibition

Archaeological discoveries which shed light on the life and times of William Shakespeare are being showcased in a new free to access virtual exhibition.3D-scanned artefacts recovered from the site of the Bard’s family home New Place feature in Searching for Shakespeare , an online museum exhibition curated by the Centre of Archaeology  at Staffordshire University in collaboration with the Shakespeare Birthplace Trust. Archaeologists from Staffordshire University carried out excavations of the site in

Brighter carries out a directed share issue of c. SEK 33 million

With authorization from the Annual General Meeting 2020, Brighter’s Board of Directors has decided to carry out a directed share issue of c. SEK 33 million to Unwrap Finance Nordic AB. Payment is made by offset of receivable of SEK 19.8 million as well as SEK 13 million in cash. The subscription price has been set at SEK 2.8, corresponding to a 10% discount compared with the volume-weighted average price of the share during the period 6 November to 7 December 2020. The purpose of the issue and the reason for the deviation from the shareholders' pre-emption rights is to strengthen the

New share-based Long-term Incentive Plans for Fiskars Group’s key employees

Fiskars CorporationStock Exchange Release   December 10, 2020 at 16:15 EET New share-based Long-term Incentive Plans for Fiskars Group’s key employees The Board of Directors of Fiskars Corporation has decided on new share-based Long-term Incentive Plans for the Fiskars Group Leadership Team and other key employees. The plans include a Performance Share Plan and a Restricted Share Plan and they will form a part of Fiskars remuneration program for its key employees. The aim of the plans is to support the implementation of the company’s strategy and drive profitable growth and to

Swedavia secures financing through Nordic Investment Bank

Swedavia and the Nordic Investment Bank (NIB) have signed a SEK 500 million loan agreement.The seven-year SEK 500 million (approximately EUR 49 million) loan agreement is a Covid-19 response loan aimed at facilitating financing for industries heavily impacted by the coronavirus pandemic. "The loan helps to further strengthen our liquidity at a time when the Covid-19 pandemic is having a dramatic effect on both air travel and Swedavia's operations," says Mats Påhlson, Swedavia's chief financial officer.During the period January-October, the number of passengers at Swedavia's airports

SaaS company Flowbox ranked number 8 in Deloitte’s Sweden Technology Fast 50 2020

Visual MarTech company Flowbox, which provides a platform for optimizing user generated content (UGC), has been ranked number 8 in Deloitte’s annual recognition of the fastest-growing tech companies in Sweden. The annual Technology Fast 50 program has been running since 1995 in over 20 different countries around the world. In Sweden, the ranking of top-performing private and public tech firms has been carried out since 2003. Company ranking is based on revenue growth over the last four years and Deloitte considers a wide range of technology companies from software and hardware to life

Skanska builds apartments in Helsinki, Finland, for EUR 34M, about SEK 350M

Skanska has signed a contract with the City of Helsinki to build new apartments in Helsinki, Finland. The contract is worth EUR 34M, about SEK 350M, to be included in the Nordic order bookings for the fourth quarter 2020.The project encompasses three apartment buildings totalling 170 subsidized apartments in Jätkäsaari district in Helsinki. The buildings will represent the highest energy efficiency class and include rooftop solar panels that will help generate some of the electricity used by the property. In addition, a wastewater heat recovery system will be installed in the tallest of the

Outokumpu – Next plan period 2021–2023 for share-based programs and 2020 share rewards in Matching Share Plan

Outokumpu OyjStock exchange releaseDecember 10, 2020 at 4.00 pm EETOutokumpu – Next plan period 2021–2023 for share-based programs and 2020 share rewards in Matching Share Plan As part of the long-term incentive programs for key employees in Outokumpu, the Board of Directors has approved the commencement of the plan period 2021–2023 for the company’s share-based programs. Furthermore, the Board approved the deliveries of the 2020 share rewards in the Matching Share Plan for Management. Plan periods for share-based programs 2021–2023 The Board of Directors has now approved the

Initiator Pharma strengthens its management team and initiates its Scientific Clinical Advisory Board

Initiator Pharma A/S, a clinical-stage biotech company, today announced the appointment of Dr. Allan Wehnert as SVP, Head of Clinical and R&D Strategy and Portfolio Management, and the formation of a Scientific and Clinical Advisory Board (SCAB). The strengthening of the clinical expertise is a direct result of Initiator Pharma’s progress in clinical development of the lead assets IPED2015 and IP2018.Dr. Allan Wehnert joins Initiator Pharma as Senior Vice President, Clinical and R&D Strategy and Portfolio Management. Allan Wehnert has close to 30 years of experience from leading positions

Resolutions at the Extraordinary General Meeting in Loomis

The Extraordinary General Meeting today in Loomis AB resolved, in accordance with the Board’s proposal, on a dividend of SEK 5.50 per share. The record date for the dividend was set to Monday, 14 December, 2020. The dividend is expected to be paid by Euroclear Sweden AB on Thursday, 17 December, 2020. Due to the ongoing corona pandemic, the Extraordinary General Meeting was carried out through postal voting, without any physical attendance. Minutes from the Extraordinary General Meeting will be available on the company’s website, www.loomis.com.

Irisity selected as an Intel AI-builders member fostering next generation AI

Irisity AB (publ) has entered into Intel AI-builders program.The Intel AI builders’ program is an enterprise ecosystem of industry-leading independent software vendors, system integrators, original equipment manufacturers, and enterprise end users who have a shared mission to accelerate the adoption of artificial intelligence across Intel platforms. Through focused collaborations, Intel Builders members accelerate optimized solutions to market and deliver tools and documentation to speed solution deployments. · “We are looking forward to being part of Intel’s AI ecosystem. This is

EPB Fiber Optics selects Smartoptics’ open line system for 100G network upgrades systems

Oslo, Norway – December 10, 2020 – Smartoptics, a leading provider of optical networking solutions, today announces that US-based EPB Power and Fiber Optics chooses Smartoptics’ open line networking solutions to scale and enhance its network services. The new solution is based on Smartoptics’ DCP-M open line system for flexible and cost-efficient DWDM connectivity. EPB, a municipally owned utility, providing electric power, Internet, TV, and phone services to residential and business customers in Chattanooga has signed an agreement with Smartoptics to deploy its DCP-M40 platform 

Bittium and Tutus Sign an Agreement of a Certified Mobile Solution for the Swedish Authorities

Press release Free for publication on December 10, 2020 at 03.00 p.m. (CET +1) Bittium and Tutus Sign an Agreement of a Certified Mobile Solution for the Swedish Authorities Oulu, Finland, December 10, 2020 – Bittium, a leading Finnish provider of mission critical communication solutions, and Tutus, a Swedish expert in certified network encryption solutions, have started a cooperation which will create an unparalleled mobile solution to be used when high security classification is needed. This solution combines Tutus' strong security expertise and Bittium’s extremely reliable

Erik Penser Bank publishes analysis of Initiator Pharma

Initiator Pharma A/S, a clinical-stage biotech company, announced that Erik Penser Bank has made an analysis of the company. Erik Penser Bank’s valuation indicates a justified value of SEK 11-12 (WACC 16%). The valuation rests on the company's two clinical projects, with IPED2015 and IP2018. For the full analysis, please follow this link .Initiator Pharma currently has an ongoing exercise period for the warrants of series TO 2. The last day to exercise the warrants is on Tuesday, the 15[th] of December 2020. For more information about the

Virginia-based dialysis provider Somatus Kidney Care partners with Redsense

Somatus Kidney Care has entered into an agreement with Redsense Medical to use the Redsense solution in the five acute programs maintained by Somatus in the Northern Virginia area. Somatus Kidney Care is a full service provider that provides integrated care for patients with or at-risk of developing kidney disease, and offers all dialysis modalities. It was established in 2016 and is headquartered in McLean, Virginia. “Somatus Kidney Care and Redsense Medical share the vision of a more personalized, accessible and compassionate kidney care that has the patients’ needs and safety in mind

Goeyvaerts grows with four more Konecranes Gottwald Mobile Harbor Cranes

In the fourth quarter of 2020, Goeyvaerts-R bvba (Goeyvaerts) ordered four more eco-efficient Konecranes Gottwald Mobile Harbor Cranes for their rental fleet across ports in the Netherlands and Belgium. The cranes will be delivered from January to October 2021.Founded in the 1950s, Goeyvaerts is a family company with nearly 70 years of logistics experience. It has a strong presence in northwestern Europe, reaching across borders and offering crane rental packages with round-the-clock technical support. Their typical customers include startups that want to reduce financial risk as they

Kemira publishes a Water Handbook for water treatment industry

Kemira, a global chemicals company serving customers in water intensive industries, has published a water treatment reference book for water treatment companies, universities, industry associations, researchers and other partners. The About Water Treatment handbook describes the methods and processes that are used today for treating potable water and waste water, not forgetting new smart process management options, enabled by digitalization. It also discusses sludge and the ways in which it is handled. The book has been created by water treatment professionals across Kemira’s global

Obstructive sleep apnoea puts a strain on the heart, too

Longer nocturnal respiratory events in patients with obstructive sleep apnoea (OSA) cause higher immediate heart rate variability, and greater changes in beat-to-beat intervals are associated with reduced daytime alertness, according to new research from the University of Eastern Finland. Obstructive sleep apnoea affects approximately 1 billion people worldwide. It is one of the most prevalent sleeping disorders, putting a great strain on national economies and on public health. Nocturnal respiratory events, be they complete or partial blocking of the airways, often cause repeated oxygen

Preparatory work for the Kemi bioproduct mill project continues in the mill area

Metsä Fibre press release 10.12.2020Preparatory work belonging to the pre-engineering for the Kemi bioproduct mill project of Metsä Fibre, part of Metsä Group, continues with new preparation activities in the mill area. The preparatory work facilitates the construction of the mill following a possible investment decision. The decision on the EUR 1.5 billion investment in the new bioproduct mill could be made in the early 2021 at the earliest, after the environmental permit process has been completed and other prerequisites for the decision are met. The preparatory work that started at

Completion of Energy4HYBRIT biomaterial sidestream prefeasibility study in Finland

The Energy4HYBRIT prefeasibility study, part of SSAB’s plan to be fossil free by 2045, has been completed. In this prefeasibility study, SSAB investigated the use of fossil-free energy sources, primarily biomaterial sidestreams, to replace fossil fuels in certain steelmaking processes, for example rolling processes. The Raahe mill in Finland acted as the reference in the project. The prefeasibility study indicates that it would be possible to replace a significant amount of fossil fuel consumption with felling and other bio-based sidestream components at the Raahe mill. “Regarding

Aegirbio’s Eurostar application concerning “COVID-19 detection” ranked 27th among 550 applicants

Aegirbio's application for financial aid from Eurostar concerning the project “A cost-effective and broadly applicable mimetope based diagnostic platform for high-impact pandemics” was ranked 27th among 550 applications. Aegirbio has, together with its German partner, submitted an application for part-financing of its precise COVID-19 antibody test to Eurostar. The decision whether to grant financing will be taken later.The project aims to develop a new platform for point-of-care (POC) serology tests, with COVID-19 as the first application. Aegirbio’s veritope molecules can be used to react

Sobi and Apellis report positive top-line results at 48 weeks from the phase 3 PEGASUS study of pegcetacoplan in PNH

Sobi and Apellis report positive top-line results at 48 weeks from the phase 3 PEGASUS study of pegcetacoplan in PNH · Treatment with pegcetacoplan resulted in a sustained improvement in haemoglobin with a mean increase from baseline of 2.7 g/dL at week 48, which is equal to the 2.7 g/dL increase seen at week 16 with pegcetacoplan-treated patients · Sustained improvements in transfusion avoidance, reticulocyte count, lactate dehydrogenase (LDH) level and Functional Assessment of Chronic Illness Therapy (FACIT)-fatigue score were observed in patients treated with pegcetacoplan ·

Proposals of the Shareholders’ Nomination Board of Terveystalo to the Annual General Meeting 2021

Terveystalo Plc Stock Exchange Release 10 December 2020 at 13:00 EET The Shareholders' Nomination Board of Terveystalo has submitted its proposal on the Board of Directors to the Annual General Meeting 2021. Proposal on the number of members of the Board of Directors and its composition The Shareholders' Nomination Board proposes to the Annual General Meeting that the number of members of the Board of Directors shall be seven (7). The Shareholders' Nomination Board proposes, for a term that ends at the end of the Annual General Meeting 2022 Dag Andersson, Kari Kauniskangas, Åse

Norwegian healthcare region has appointed Sectra as enterprise imaging vendor for efficient region-wide patient care

Linköping, Sweden – December 10, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has secured an enterprise imaging contract from the South-Eastern Norway Regional Health Authority. The contract comprises a radiology module and a region-wide multimedia solution (VNA) to store medical images and multimedia across all medical specialties. The platform will increase efficiency and collaboration across the region and beyond, translating into improved healthcare for its patients.“We are pleased that we have the agreement in place. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top